North Little Rock, Arkansas Clinical Trials

A listing of North Little Rock, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 128 clinical trials
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)

To evaluate the treatment effect of seladelpar on composite biochemical improvement in cholestasis markers based on ALP and total bilirubin and to evaluate the safety of seladelpar over 12 months of treatment compared to placebo

Arkansas Diagnostic Center
 (4.6 away) Contact site
  • 0 views
  • 17 Jun, 2021
  • +22 other locations
Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 2b adaptive dose-finding study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Little Rock Allergy and Asthma Clinical Research Center
 (4.6 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +122 other locations
A Study to Assess the Efficacy Safety and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

USA044
 (5.1 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +199 other locations
A Dose Ranging Study Evaluating Efficacy and Safety of NI-03

The purpose of this study is to determine the safety and efficacy of NI-03.

morphine
analgesics
University of Arkansas
 (5.2 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +64 other locations
Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression Agitation and Irritability in Patients With Traumatic Brain Injury

This is a multicenter, randomized, placebo-controlled study to evaluate AVP-786 for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in participants with traumatic brain injury (TBI).

MS Clinic of Arkansas
 (7.9 away) Contact site
  • 3060 views
  • 04 Jun, 2021
  • +83 other locations
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

metastatic colorectal cancer
tumor cells
liver metastasis
rifampin
oxaliplatin
John L McClellan Memorial Veterans Hospital
 (4.6 away) Contact site
  • 65 views
  • 18 Jun, 2021
  • +972 other locations
Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects 1 Month to <17 Years Undergoing MRI Scans

This is a randomized, double-blind, dose-ranging study of the efficacy and safety of dexmedetomidine (DEX) when used with propofol as needed, for procedural sedation of pediatric subjects 1 month to <17 years of age undergoing MRI scans in the US and Japan.

Arkansas Children's
 (2.9 away) Contact site
  • 5 views
  • 17 Jun, 2021
  • +35 other locations
CLE-100 as an Oral Therapy in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

The clinical trial is a Phase 2, double-blind, randomized, placebo controlled study in Major Depressive Disorder (MDD) participants currently treated with antidepressant therapy. The objective of the study is to assess CLE-100 for the treatment of MDD in participants currently treated with standard antidepressant therapy.

Clinical Site 120
 (8.1 away) Contact site
  • 2 views
  • 16 Jun, 2021
  • +22 other locations
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy

The purpose of this study is to evaluate the efficacy and safety of intramuscular (IM) administration of Engensis on pain in participants with painful diabetic peripheral neuropathy (DPN) in the feet and lower legs, as compared to Placebo, as a second Phase 3, well controlled study, sufficient in supporting the …

pregabalin
glycosylated hemoglobin
peripheral neuropathy
gabapentin
diabetic peripheral neuropathy
Clinical Trials - Little Rosk
 (5.1 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +17 other locations
Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

This phase 3b study will evaluate long-term safety and efficacy of CSL312 (also known as garadacimab) when administered subcutaneously (SC)

angioedema
Little Rock Allergy & Asthma Clinic
 (5.1 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +5 other locations